PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: ZOLL Medical Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

ZOLL Medical Awarded Welsh Ambulance Services NHS Trust Contract for EMS Monitor Defibrillators - Largest order for ZOLL E Series to date in the United Kingdom (Nasdaq GS: ZOLL)
ZOLL Medical Awarded Welsh Ambulance Services NHS Trust Contract for EMS Monitor Defibrillators

 

NewswireToday - /newswire/ - Chelmsford, MA, United States, 2011/04/28 - Largest order for ZOLL E Series to date in the United Kingdom (Nasdaq GS: ZOLL). NASDAQ: ZOLL

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Welsh Ambulance Services (WAST) NHS is equipping its frontline ambulances with the ZOLL E Series® EMS monitor/defibrillator. Under the terms of the agreement, ZOLL plans to supply a total of 185 E Series units for distribution to the north, central and west, and southeast regions of the Welsh Service.

This contract, valued at $1.7 million (U.S.), is the largest order to date for the E Series in the United Kingdom. A ZOLL customer for 12 years, WAST is standardized on the Company’s monitor/defibrillator products and updated to the E Series two years ago when it purchased 54 E Series units.

“From the outset, we’ve been impressed with the impact the full-featured E Series offers in improving outcomes from sudden cardiac arrest. The 12-lead STEMI option gives us the ability to simultaneously share information with the ED so they are prepared when the patient arrives,” said a WAST spokesperson. “And throughout our relationship with ZOLL, we’ve come to rely on them for excellent customer service.”

“ZOLL is pleased that the Welsh Ambulance Service Trust continues to use ZOLL as a partner in its mission to offer the best critical care for Welsh citizens. This upgrade of equipment demonstrates the value they place on advancing resuscitation care and we are pleased they continue to use ZOLL as a partner to help save more lives,” said Jonathan A. Rennert, President of ZOLL.

About the E Series
The rugged E Series monitor/defibrillator continues to set the standard in EMS resuscitation, providing proven high-current biphasic defibrillation capability and a wide range of unparalleled treatment and monitoring technologies. It is also the leader in fully integrated EMS data management, yet also offers the flexibility to communicate with other patient information and code data systems as required.

About Sudden Cardiac Arrest
Sudden cardiac arrest, an abrupt disruption of the heart’s function, which causes a lack of blood flow to vital organs, claims between 150,000 and 180,000 lives each year in the United Kingdom. It is the leading cause of unexpected death in the world and strikes without warning. Currently, only about 5 percent of victims survive, but improvements in resuscitation care could probably increase this to as high as 25-50 percent.

About the Welsh Ambulance Services NHS Trust
Serving a population of 2.9 million, spread out over an area of nearly 13,000 miles, WAST serves a diverse area that encompasses tranquil rural retreats, busy seaside resorts, and large urban communities. Its varied and modern services are tailored to address the different environments and their medical needs. WAST responds to more than 250,000 emergency calls annually and over 50,000 urgent calls, and transports over 1.3 million non-emergency patients to over 200 treatment centers throughout England and Wales. It operates 90 ambulance stations, four control centers, three regional offices, and five vehicle workshops, and employs a staff of 2,576 people, 76 percent of whom are operational.

About ZOLL Medical Corporation
ZOLL Medical Corporation (zoll.com) develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies which help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company in 2007, 2008, and 2009, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe.

Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Annual Report on Form 10-K filed with the SEC on December 17, 2010. You should not place undue reliance on the forward looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.

Copyright © 2011 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL is a registered trademark of ZOLL Medical Corporation in the United States and/or other countries. NorthFace ScoreBoard Award is a service mark of Omega Management Group Corporation. All product names are the property of their respective owners.

Investor Contact:
A. Ernest Whiton, Chief Financial Officer
ZOLL Medical Corporation
P: +1 (978) 421-9655

Media Contact:
Jill Garratt, ZOLL Medical UK Ltd
P: +44 01928 595 160 / E: jgarratt[.]zoll.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: ZOLL Medical Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


ZOLL Medical Awarded Welsh Ambulance Services NHS Trust Contract for EMS Monitor Defibrillators

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Diane Egan - Zoll.com 
978-421-9637 degan[.]zoll.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ZOLL Medical Corporation securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From ZOLL Medical Corporation / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps
Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)